These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 5425873)

  • 1. Morgellons disease: A myth or reality?
    Ranka N; Godse K; Nadkarni N; Patil S; Agarwal S
    Indian Dermatol Online J; 2016; 7(5):430-432. PubMed ID: 27730047
    [No Abstract]   [Full Text] [Related]  

  • 2. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ; Elizan TS
    J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 4. Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
    Barjon P; Fourcade J; Mimran A; Charra B
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):187-92. PubMed ID: 5055013
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa and Parkinsonism.
    Lond Clin Med J; 1970 Jan; 11(1):5-7. PubMed ID: 5504130
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa for Parkinsonism.
    Drug Ther Bull; 1969 Jul; 7(15):59-60. PubMed ID: 5806494
    [No Abstract]   [Full Text] [Related]  

  • 7. [L-Dopa in parkinsonism, myth or reality].
    Henry P
    Bord Med; 1970 Feb; 3(2):393-7. PubMed ID: 5425873
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa in the treatment of parkinsonism].
    Goldsztajn M; Reichowa J
    Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long term treatment of a parkinsonism with l-dopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factors which influence infavourably l-dopa treatment].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2115-6. PubMed ID: 4590071
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa metabolism in man (with special reference to parkinsonism).
    Sandler M
    Sci Basis Med Annu Rev; 1972; ():161-73. PubMed ID: 4564341
    [No Abstract]   [Full Text] [Related]  

  • 12. L-Dopa in the treatment of parkinsonism.
    Calne DB
    Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.